BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bozkurt L, Göbl CS, Tura A, Chmelik M, Prikoszovich T, Kosi L, Wagner O, Roden M, Pacini G, Gastaldelli A. Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS One. 2012;7:e32710. [PMID: 22393439 DOI: 10.1371/journal.pone.0032710] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Tian M, Ma S, You Y, Long S, Zhang J, Guo C, Wang X, Tan H. Serum Metabolites as an Indicator of Developing Gestational Diabetes Mellitus Later in the Pregnancy: A Prospective Cohort of a Chinese Population. J Diabetes Res 2021;2021:8885954. [PMID: 33628838 DOI: 10.1155/2021/8885954] [Reference Citation Analysis]
2 Leutner M, Göbl C, Schlager O, Charwat-Resl S, Wielandner A, Howorka E, Prünner M, Bozkurt L, Maruszczak K, Geyik H, Prosch H, Pacini G, Kautzky-Willer A. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients. J Am Coll Nutr 2017;36:287-94. [PMID: 28506114 DOI: 10.1080/07315724.2016.1262802] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Cuthbertson DJ, Weickert MO, Lythgoe D, Sprung VS, Dobson R, Shoajee-Moradie F, Umpleby M, Pfeiffer AF, Thomas EL, Bell JD. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. Eur J Endocrinol. 2014;171:561-569. [PMID: 25298375 DOI: 10.1530/eje-14-0112] [Cited by in Crossref: 75] [Cited by in F6Publishing: 37] [Article Influence: 10.7] [Reference Citation Analysis]
4 Mousa N, Abdel-razik A, Shams M, Sheta T, Zakaria S, Shabana W, Effat N, El-diasty M, Abed S, Abd Elsalam M, Awad M, Salah M, El-wakeel N, Deiab A, Eldars W. Impact of non-alcoholic fatty liver disease on pregnancy. British Journal of Biomedical Science 2018;75:197-9. [DOI: 10.1080/09674845.2018.1492205] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
5 Sviklāne L, Olmane E, Dzērve Z, Kupčs K, Pīrāgs V, Sokolovska J. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes. J Gastroenterol Hepatol 2018;33:270-6. [PMID: 28464337 DOI: 10.1111/jgh.13814] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
6 Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev. 2016;37:278-316. [PMID: 27159875 DOI: 10.1210/er.2015-1137] [Cited by in Crossref: 540] [Cited by in F6Publishing: 480] [Article Influence: 90.0] [Reference Citation Analysis]
7 Kantartzis K, Rettig I, Staiger H, Machann J, Schick F, Scheja L, Gastaldelli A, Bugianesi E, Peter A, Schulze M, Fritsche A, Häring H, Stefan N. An extended fatty liver index to predict non-alcoholic fatty liver disease. Diabetes & Metabolism 2017;43:229-39. [DOI: 10.1016/j.diabet.2016.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
8 Movahedian M, Rahmani J, Hashemi Nazari SS, Mohamadi S, Naik G, Hekmatdoost A. Fatty liver index and risk of diabetes incidence: A systematic review and dose-response meta-analysis of cohort studies. Prim Care Diabetes 2020;14:577-83. [PMID: 32694004 DOI: 10.1016/j.pcd.2020.02.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Siegert S, Yu Z, Wang-Sattler R, Illig T, Adamski J, Hampe J, Nikolaus S, Schreiber S, Krawczak M, Nothnagel M. Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers. PLoS One. 2013;8:e76813. [PMID: 24130792 DOI: 10.1371/journal.pone.0076813] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
10 Donnelly SR, Hinkle SN, Rawal S, Grunnet LG, Chavarro JE, Vaag A, Wu J, Damm P, Mills JL, Li M, Bjerregaard AA, Thuesen ACB, Gore-Langton RE, Francis EC, Ley SH, Hu FB, Tsai MY, Olsen SF, Zhang C. Prospective study of gestational diabetes and fatty liver scores 9 to 16 years after pregnancy. J Diabetes 2019;11:895-905. [PMID: 31001915 DOI: 10.1111/1753-0407.12934] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol 2016;111:658-64. [PMID: 27002796 DOI: 10.1038/ajg.2016.57] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
12 Fedchuk L, Nascimbeni F, Pais R, Charlotte F, Housset C, Ratziu V; LIDO Study Group. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2014;40:1209-1222. [PMID: 25267215 DOI: 10.1111/apt.12963] [Cited by in Crossref: 151] [Cited by in F6Publishing: 142] [Article Influence: 18.9] [Reference Citation Analysis]
13 Miya A, Nakamura A, Miyoshi H, Ukawa S, Nakamura K, Nakagawa T, Terauchi Y, Tamakoshi A, Atsumi T. Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study. J Diabetes Investig 2020;11:964-70. [PMID: 31999890 DOI: 10.1111/jdi.13221] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Auer MK, Stalla GK, Stieg MR. Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas. Pituitary 2016;19:461-71. [PMID: 27194386 DOI: 10.1007/s11102-016-0726-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
15 Pathirana MM, Lassi Z, Ali A, Arstall M, Roberts CT, Andraweera PH. Cardiovascular risk factors in women with previous gestational diabetes mellitus: A systematic review and meta-analysis. Rev Endocr Metab Disord 2020. [PMID: 33106997 DOI: 10.1007/s11154-020-09587-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Jeon WS, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Lee WY. Association of serum adipocyte-specific Fatty Acid binding protein with Fatty liver index as a predictive indicator of nonalcoholic Fatty liver disease. Endocrinol Metab (Seoul). 2013;28:283-287. [PMID: 24396693 DOI: 10.3803/EnM.2013.28.4.283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sridhar SB, Xu F, Darbinian J, Quesenberry CP, Ferrara A, Hedderson MM. Pregravid liver enzyme levels and risk of gestational diabetes mellitus during a subsequent pregnancy. Diabetes Care 2014;37:1878-84. [PMID: 24795397 DOI: 10.2337/dc13-2229] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
18 Bozkurt L, Göbl CS, Baumgartner-Parzer S, Luger A, Pacini G, Kautzky-Willer A. Adiponectin and Leptin at Early Pregnancy: Association to Actual Glucose Disposal and Risk for GDM-A Prospective Cohort Study. Int J Endocrinol 2018;2018:5463762. [PMID: 30123262 DOI: 10.1155/2018/5463762] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
19 Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age? World J Gastroenterol 2014; 20(27): 9072-9089 [PMID: 25083080 DOI: 10.3748/wjg.v20.i27.9072] [Cited by in F6Publishing: 47] [Reference Citation Analysis]
20 Nishi T, Babazono A, Maeda T, Imatoh T, Une H. Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes. J Diabetes Investig 2015;6:309-16. [PMID: 25969716 DOI: 10.1111/jdi.12290] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
21 Harreiter J, Dovjak G, Kautzky-Willer A. Gestational diabetes mellitus and cardiovascular risk after pregnancy. Womens Health (Lond) 2014;10:91-108. [PMID: 24328601 DOI: 10.2217/whe.13.69] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
22 Lee SM, Kwak SH, Koo JN, Oh IH, Kwon JE, Kim BJ, Kim SM, Kim SY, Kim GM, Joo SK, Koo BK, Shin S, Vixay C, Norwitz ER, Park C, Jun JK, Kim W, Park JS. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia 2019;62:238-48. [DOI: 10.1007/s00125-018-4779-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
23 Franch-Nadal J, Caballeria L, Mata-Cases M, Mauricio D, Giraldez-García C, Mancera J, Goday A, Mundet-Tudurí X, Regidor E; PREDAPS Study Group. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. PLoS One 2018;13:e0198327. [PMID: 29856820 DOI: 10.1371/journal.pone.0198327] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
24 Göbl CS, Bozkurt L, Prikoszovich T, Tura A, Pacini G, Kautzky-Willer A. Estimating the risk after gestational diabetes mellitus: can we improve the information from the postpartum OGTT? Am J Physiol Endocrinol Metab. 2013;304:E524-E530. [PMID: 23299502 DOI: 10.1152/ajpendo.00461.2012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
25 Jung TY, Kim MS, Hong HP, Kang KA, Jun DW. Comparative Assessment and External Validation of Hepatic Steatosis Formulae in a Community-Based Setting. J Clin Med 2020;9:E2851. [PMID: 32899243 DOI: 10.3390/jcm9092851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Kahl S, Straßburger K, Nowotny B, Livingstone R, Klüppelholz B, Keßel K, Hwang JH, Giani G, Hoffmann B, Pacini G. Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PLoS One. 2014;9:e94059. [PMID: 24732091 DOI: 10.1371/journal.pone.0094059] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 9.4] [Reference Citation Analysis]
27 Göbl CS, Bozkurt L, Yarragudi R, Tura A, Pacini G, Kautzky-willer A. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus? Acta Diabetol 2014;51:715-22. [DOI: 10.1007/s00592-014-0574-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
28 Forbes S, Godsland IF, Taylor-robinson SD, Bell JD, Thomas EL, Patel N, Hamilton G, Parker KH, Marshall I, Gray CD, Bedford D, Caslake M, Walker BR, Johnston DG. A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. Diabetologia 2013;56:2021-33. [DOI: 10.1007/s00125-013-2956-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
29 Cheng YL, Wang YJ, Lan KH, Huo TI, Huang YH, Su CW, Hsieh WY, Hou MC, Lin HC, Lee FY, Wu JC, Lee SD. Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease. Gastroenterol Res Pract 2017;2017:9279836. [PMID: 28194177 DOI: 10.1155/2017/9279836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
30 Göbl CS, Bozkurt L, Rivic P, Schernthaner G, Weitgasser R, Pacini G, Mittlböck M, Bancher-todesca D, Lechleitner M, Kautzky-willer A. A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus. Diabetologia 2012;55:3173-81. [DOI: 10.1007/s00125-012-2726-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
31 Sokup A, Ruszkowska-Ciastek B, Walentowicz-Sadłecka M. Heterogeneity of cardiovascular risk factors profile in non-diabetic women 2-24 months post gestational diabetes mellitus. Gynecol Endocrinol 2014;30:350-4. [PMID: 24734889 DOI: 10.3109/09513590.2013.831830] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Göbl CS, Bozkurt L, Yarragudi R, Prikoszovich T, Tura A, Pacini G, Koppensteiner R, Kautzky-Willer A. Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus. Cardiovasc Diabetol 2014;13:138. [PMID: 25281032 DOI: 10.1186/s12933-014-0138-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
33 Ferrannini E. Definition of intervention points in prediabetes. Lancet Diabetes Endocrinol 2014;2:667-75. [PMID: 24731662 DOI: 10.1016/S2213-8587(13)70175-X] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
34 Bernardini M, Morettini M, Romeo L, Frontoni E, Burattini L. TyG-er: An ensemble Regression Forest approach for identification of clinical factors related to insulin resistance condition using Electronic Health Records. Comput Biol Med 2019;112:103358. [PMID: 31336327 DOI: 10.1016/j.compbiomed.2019.103358] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
35 Bozkurt L, Göbl CS, Pfligl L, Leitner K, Bancher-Todesca D, Luger A, Baumgartner-Parzer S, Pacini G, Kautzky-Willer A. Pathophysiological characteristics and effects of obesity in women with early and late manifestation of gestational diabetes diagnosed by the International Association of Diabetes and Pregnancy Study Groups criteria. J Clin Endocrinol Metab 2015;100:1113-20. [PMID: 25574889 DOI: 10.1210/jc.2014-4055] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
36 Sokup A, Ruszkowska-Ciastek B, Walentowicz-Sadłecka M, Grabiec M, Rość D. Gestational diabetes mellitus worsens the profile of cardiometabolic risk markers and decrease indexes of beta-cell function independently of insulin resistance in nondiabetic women with a parental history of type 2 diabetes. J Diabetes Res 2014;2014:743495. [PMID: 25097861 DOI: 10.1155/2014/743495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]